Fusion Antibodies uses proprietary technology to rapidly produce fusion proteins from novel genes and uses these products as antigens for the production and purification of antibodies.
Chairman:
Sir John Cadogan
Manging Director / CEO:
Professor James Johnston
Shareholders:
Tel:
(028) 9043 2800
Fax:
(028) 90020446
Email:
Website: